BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26131043)

  • 1. An exploratory study of the patient experience of pharmacist supplementary prescribing in a secondary care mental health setting.
    Deslandes RE; John DN; Deslandes PN
    Pharm Pract (Granada); 2015; 13(2):553. PubMed ID: 26131043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacist supplementary prescribing: a step toward more independence?
    Dawoud D; Griffiths P; Maben J; Goodyer L; Greene R
    Res Social Adm Pharm; 2011 Sep; 7(3):246-56. PubMed ID: 21272547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'It's showed me the skills that he has': pharmacists' and mentors' views on pharmacist supplementary prescribing.
    Lloyd F; Parsons C; Hughes CM
    Int J Pharm Pract; 2010 Feb; 18(1):29-36. PubMed ID: 20405593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacist prescribing in the UK - a literature review of current practice and research.
    Tonna AP; Stewart D; West B; McCaig D
    J Clin Pharm Ther; 2007 Dec; 32(6):545-56. PubMed ID: 18021331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacist prescribing in primary care: the views of patients across Great Britain who had experienced the service.
    Stewart DC; Maclure K; Bond CM; Cunningham S; Diack L; George J; McCaig DJ
    Int J Pharm Pract; 2011 Oct; 19(5):328-32. PubMed ID: 21899612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacist-led medication therapy management of diabetes club patients at a primary healthcare clinic in Cape Town, South Africa: A retrospective and prospective audit.
    Sonday F; Bheekie A; Van Huyssteen M
    S Afr Med J; 2022 May; 112(6):437-445. PubMed ID: 36217874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacist prescribing: A scoping review about the views and experiences of patients and the public.
    Famiyeh IM; McCarthy L
    Res Social Adm Pharm; 2017; 13(1):1-16. PubMed ID: 26898951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collaborative pharmacist prescribing within the opioid substitution treatment program in South Australia: Patient and pharmacist views.
    Le PP; Braunack-Mayer A; Laurence C
    Res Social Adm Pharm; 2018 Feb; 14(2):187-195. PubMed ID: 28325527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient satisfaction from two studies of collaborative doctor-pharmacist prescribing in Australia.
    Hale A; Coombes I; Stokes J; Aitken S; Clark F; Nissen L
    Health Expect; 2016 Feb; 19(1):49-61. PubMed ID: 25614342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropharmacology and mental health nurse prescribers.
    Skingsley D; Bradley EJ; Nolan P
    J Clin Nurs; 2006 Aug; 15(8):989-97. PubMed ID: 16879543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of prescribing activity within primary care in Scotland 2013-2022 of general practitioners, nurse, pharmacist and allied health prescribers: A retrospective cross-sectional study.
    MacVicar S; Paterson RE
    J Adv Nurs; 2023 Aug; 79(8):3092-3101. PubMed ID: 36971201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of pharmacist independent prescribers into general practice: a mixed-methods study of pharmacists' and patients' views.
    Alshehri AA; Hindi AMK; Cheema E; Sayeed Haque M; Jalal Z; Yahyouche A
    J Pharm Policy Pract; 2023 Jan; 16(1):10. PubMed ID: 36658624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacist prescribing in Northern Ireland: a quantitative assessment.
    McCann L; Haughey S; Parsons C; Lloyd F; Crealey G; Gormley GJ; Hughes CM
    Int J Clin Pharm; 2011 Oct; 33(5):824-31. PubMed ID: 21830075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of organisational climate on care of patients with schizophrenia: a qualitative analysis of health care professionals' views.
    Sutton J; Family HE; Scott JA; Gage H; Taylor DA
    Int J Clin Pharm; 2016 Apr; 38(2):344-52. PubMed ID: 26797771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient experiences of pharmacist independent prescriber-led post-myocardial infarction left ventricular systolic dysfunction clinics.
    Speirits IA; Boyter AC; Dunlop E; Gray K; Moir L; Forsyth P
    Int J Pharm Pract; 2021 Feb; 29(1):55-60. PubMed ID: 32786143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent extended and supplementary nurse prescribing practice in the UK: a national questionnaire survey.
    Courtenay M; Carey N; Burke J
    Int J Nurs Stud; 2007 Sep; 44(7):1093-101. PubMed ID: 16750832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care.
    Weeks G; George J; Maclure K; Stewart D
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD011227. PubMed ID: 27873322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of prescribing error and pharmacist's intervention on obstetrics and gynaecology outpatient prescriptions in a Malaysian tertiary hospital.
    Narayanan J; Balan S; Li Ling O; Kasim N; Johny P
    J Obstet Gynaecol; 2022 Aug; 42(6):2360-2366. PubMed ID: 35476628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mental health nurse supplementary prescribing: experiences of mental health nurses, psychiatrists and patients.
    Jones M; Bennett J; Lucas B; Miller D; Gray R
    J Adv Nurs; 2007 Sep; 59(5):488-96. PubMed ID: 17681079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supplementary prescribing by community and primary care pharmacists: an analysis of PACT data, 2004-2006.
    Guillaume L; Cooper R; Avery A; Mitchell S; Ward P; Anderson C; Bissell P; Hutchinson A; James V; Lymn J; McIntosh A; Murphy E; Ratcliffe J
    J Clin Pharm Ther; 2008 Feb; 33(1):11-6. PubMed ID: 18211611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.